Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytochrome P450 family 2 subfamily C member 23, pseudogene (CYP2C23P), also known as CYP2C62P, is a human gene classified as a pseudogene. Pseudogenes are DNA sequences that resemble functional genes but lack the ability to encode functional proteins, often due to disabling mutations or regulatory differences. CYP2C23P is part of the cytochrome P450 superfamily, which contains many functional genes and pseudogenes involved in diverse biochemical pathways, notably xenobiotic and drug metabolism. However, since CYP2C23P is a pseudogene, it does not encode an active enzyme and has no direct biological or pharmacological role[7][6][11].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome P450 family 2 subfamily C member 23, pseudogene (CYP2C23P).